Leone Patterson
Net worth: 12 159 $ as of 30/09/2026
Net worth: 12 159 $ as of 30/09/2026
Ms. Leone D.
Patterson is an Independent Director at Kalaris Therapeutics, Inc., an Executive VP, Chief Business & Financial Officer at Zymeworks BC, Inc. and an Independent Director at Nkarta, Inc. She is on the Board of Directors at IRulya Therapeutics, Inc., Kalaris Therapeutics, Inc. and Nkarta, Inc. Ms. Patterson was previously employed as an Executive VP, Chief Financial & Business Officer by Zymeworks, Inc., an Independent Non-Executive Director by Oxford Biomedica Plc, a Chief Financial & Business Officer by Tenaya Therapeutics, Inc., an Independent Director by Climb Bio, Inc., a President, Chief Financial & Accounting Officer by Adverum Biotechnologies, Inc., a Chief Financial Officer by Diadexus, Inc., a Chief Financial Officer & Vice President by Pivot Acquisition, Inc., a Vice President & Global Corporate Controller by NetApp, Inc., a Vice President-Finance by Exelixis, Inc., a VP-Global Business Planning & Analysis by Novartis AG, a Vice President & Corporate Controller by Chiron Corp., and a Senior Manager by KPMG LLP.
She received her undergraduate degree from Chapman University and an MBA from St. Mary's College (Indiana).
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 06/01/2026 | 459 ( 0% ) | 12 159 $ | 30/09/2026 | |
-.--% | 03/06/2026 | 0 ( -.--% ) | - $ | 30/09/2026 |
NKARTA, INC. -.--% | 10/06/2026 | 0 ( -.--% ) | - $ | 30/09/2026 |
| Companies | Position | Start |
|---|---|---|
| NKARTA, INC. | Director/Board Member | 27/04/2020 |
| IRULYA THERAPEUTICS INC. | Director/Board Member | 08/10/2026 |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Director of Finance/CFO | 01/09/2024 |
| Companies | Position | End |
|---|---|---|
| ZYMEWORKS INC. | Director of Finance/CFO | 07/01/2026 |
| OXFORD BIOMEDICA PLC | Director/Board Member | 31/12/2024 |
| CLIMB BIO, INC. | Director/Board Member | 01/12/2024 |
| TENAYA THERAPEUTICS, INC. | Director of Finance/CFO | 14/08/2024 |
| ADVERUM BIOTECHNOLOGIES, INC. | Chief Executive Officer | 15/06/2020 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 17 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Exelixis, Inc.
Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Health Technology |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Commercial Services |
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Oxford Biomedica Plc
Oxford Biomedica Plc BiotechnologyHealth Technology Operates as a contract development and manufacturing organization which provides viral vectors to pharmaceutical and biotechnology clients in cell and gene therapy fields | Health Technology |
Chapman University
Chapman University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St. Mary's College (Indiana)
St. Mary's College (Indiana) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NetApp, Inc.
NetApp, Inc. Computer PeripheralsElectronic Technology Provides data management and storage solutions | Electronic Technology |
Transcept Pharma, Inc.
Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Diadexus, Inc.
Diadexus, Inc. Medical SpecialtiesHealth Technology Develops and commercializes patent-protected in vitro diagnostic products | Health Technology |
Adverum Biotechnologies, Inc.
Adverum Biotechnologies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company that develops gene therapies | Health Technology |
Quince Therapeutics, Inc.
Quince Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of central nervous system disorders and Alzheimer’s diseases | Health Technology |
Nkarta, Inc.
Nkarta, Inc. BiotechnologyHealth Technology Discovers, develops and delivers NK cell therapies for cancer treatment | Health Technology |
Tenaya Therapeutics, Inc.
Tenaya Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for heart failure | Health Technology |
Eliem Therapeutics, Inc.
Eliem Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders | Health Technology |
Zymeworks, Inc.
Zymeworks, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Select your edition
All financial news and data tailored to specific country editions